1. Home
  2. CVNA vs NTRA Comparison

CVNA vs NTRA Comparison

Compare CVNA & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carvana Co.

CVNA

Carvana Co.

N/A

Current Price

$73.94

Market Cap

43.3B

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$338.45

Market Cap

45.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVNA
NTRA
Founded
2012
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3B
45.3B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
CVNA
NTRA
Price
$73.94
$338.45
Analyst Decision
Buy
Strong Buy
Analyst Count
24
15
Target Price
$439.67
$259.07
AVG Volume (30 Days)
9.3M
1.4M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
431.45
0.65
EPS
8.45
N/A
Revenue
$20,322,000,000.00
$210,939,000.00
Revenue This Year
$34.66
$18.08
Revenue Next Year
$23.38
$19.65
P/E Ratio
$8.96
N/A
Revenue Growth
48.63
N/A
52 Week Low
$56.12
$157.43
52 Week High
$486.89
$337.12

Technical Indicators

Market Signals
Indicator
CVNA
NTRA
Relative Strength Index (RSI) 58.01 72.33
Support Level $62.23 $187.64
Resistance Level $418.77 N/A
Average True Range (ATR) 3.44 10.88
MACD 0.86 1.95
Stochastic Oscillator 96.84 100.00

Price Performance

Historical Comparison
CVNA
NTRA

About CVNA Carvana Co.

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: